- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06609824
Learn to Dare! Leiden
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants are recruited via the 'Knowledge Centre Anxiety and Stress in youth' (KAS) telephone line, by a research assistant or via the waiting list of LUBEC. Following recruitment, a research assistant conducts a screening call with the parent(s) lasting approximately half an hour to determine the child's eligibility for the project. Subsequently, the research assistant collaborates with a therapist from KAS/LUBEC to evaluate the case. If both agree that the child meets the criteria of the 'Learn to Dare!' program, the research assistant proceeds to conduct a diagnostic interview with both the child and parents. When the child still meets the requirements for 'Learn to Dare!', the therapist from LUBEC, who is going to give the trainings, will do an intake with the child and parents.
When the child still meets the criteria after this intake, a subsequent appointment will take place at LUBEC in Leiden, that serves as an opportunity for parents and children to familiarize themselves with the therapist and complete the baseline 1 measurement. This appointment will take about 1,5-2 hours. Two research assistants will administer questionnaires to the parent(s) and the child: demographics questionnaire, SCARED, CDI, WIRK-ALL. In addition, they will administer the anxiety scale of the SCID in combination with the ADIS severity index to the parent(s) and the child.
After baseline 1, there will be a waiting period of 4 weeks. After this period, the child and parents complete the SCARED questionnaire online (30 minutes) before commencing the treatment phase. The treatment comprises eight group sessions of 'Learn to Dare!' (one session per week; 1.5 hours each) along with assigned homework. After those eight weeks of treatment, the post-treatment session will take place at LUBEC (1,5-2 hours). The therapist will meet with the child and the parent(s) to evaluate the treatment together. The research assistants will administer the anxiety scale of the SCID in combination with the ADIS severity index to the parent(s) and the child. In addition, a couple of questionnaires will be administered: SCARED, CDI, WIRK-ALL, Training Evaluation Questionnaire. Lastly, there will be three follow-ups 6, 12, and 24 months after treatment (1,5 hours per follow-up). Parents have the option to conduct these follow-ups either at LUBEC or online. The anxiety scale of the SCID, along with the severity index of the ADIS questionnaire, is administered, along with supplementary questionnaires: SCARED, CDI, WIRK-ALL.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anke M Klein, AS
- Phone Number: +31655111908
- Email: a.m.klein@fsw.leidenuniv.nl
Study Contact Backup
- Name: Anika Bexkens, AS
- Phone Number: +31715276566
- Email: a.bexkens@fsw.leidenuniv.nl
Study Locations
-
-
South-Holland
-
Leiden, South-Holland, Netherlands, 2333AK
- Recruiting
- Leiden University
-
Contact:
- Anke M Klein, AS
- Phone Number: +31655111908
- Email: a.m.klein@fsw.leidenuniv.nl
-
Contact:
- Anika Bexkens, AS
- Phone Number: +31715276566
- Email: a.bexkens@fsw.leidenuniv.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Cut-off scores of the SCARED: for girls 31 and for boys 27.
Exclusion Criteria:
- Currently under treatment for anxiety complaints or under treatment in the mental health care system for other internalizing complaints.
- Anxiety problems or comorbid problems that require attention or treatment (including a 6 or higher on the severity index (CSR) of the ADIS and a score above the clinical cut-off on the Child Depression Inventory.)
- Difficulty in understanding the training.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Training Group
This arm consists of all participants who receive the training intervention.
The purpose is to assess longitudinal effectiveness of the training within all participants.
|
'Leer te Durven!' is an eight-week preventative group training for children between the ages of 8 and 12.
This training is evidence-based and is based on the principles of Cognitive Behavioral Therapy.
With this program children learn to stand up for themselves in a safe environment, to face the situations that they find exciting and to be more confident in their own abilities.
The training consists, among other things, of psychoeducation, exposure, and relaxation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in anxiety severity in children (SCARED-child)
Time Frame: During baseline 1, baseline 2, post-training, and the follow-ups (6, 12, and 24 months after the training)
|
The Screen for Child Anxiety Related Disorders (SCARED) will be administered to the children.
Scores on the SCARED range between 0-142.
A higher score means higher anxiety levels.
|
During baseline 1, baseline 2, post-training, and the follow-ups (6, 12, and 24 months after the training)
|
|
Change in anxiety severity in children (SCARED-parent)
Time Frame: During baseline 1, baseline 2, post-training, and the follow-ups (6, 12, and 24 months after the training)
|
The Screen for Child Anxiety Related Disorders (SCARED) will be administered to the parents.
Scores on the SCARED range between 0-142.
A higher score means higher anxiety levels.
|
During baseline 1, baseline 2, post-training, and the follow-ups (6, 12, and 24 months after the training)
|
|
Change in severity of anxiety in children (SCID-parent)
Time Frame: From baseline to the end of the training and follow-up (6, 12, and 24 months post-training).
|
Severity of anxiety will be assessed using the Structured Clinical Interview for DSM Disorders (SCID) in combination with the severity index (Clinician Severity Rating) of the Anxiety Disorder Interview Schedule (ADIS-V).
The CSR-score is a score between 0 and 8, with higher scores indicating a higher severity and interference of anxiety.
The SCID will be administered to the parents.
|
From baseline to the end of the training and follow-up (6, 12, and 24 months post-training).
|
|
Change in severity of anxiety in children (SCID-child)
Time Frame: From baseline to the end of the training and follow-up (6, 12, and 24 months post-training).
|
Severity of anxiety will be assessed using the Structured Clinical Interview for DSM Disorders (SCID) in combination with the severity index (Clinician Severity Rating) of the Anxiety Disorder Interview Schedule (ADIS-V).
The CSR-score is a score between 0 and 8, with higher scores indicating a higher severity and interference of anxiety.
The SCID will be administered to the children.
|
From baseline to the end of the training and follow-up (6, 12, and 24 months post-training).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in self-efficacy of the children (WIRK-ALL child version)
Time Frame: From baseline to the end of the training and follow-up (6, 12, and 24 months post-training).
|
The WIRK-all will be administered to the children to assess their change in self-efficacy.
The WIRK-ALL is a short questionnaire and is an adaptation of the General Self-Efficacy Scale.
The scores on the WIRK-ALL range between 10 and 40, with higher scores indicating higher self-efficacy.
|
From baseline to the end of the training and follow-up (6, 12, and 24 months post-training).
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anke M Klein, AS, Leiden University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2024-02-27-A.M. Klein-V2-5116
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shyness
-
University of OxfordAustralian National UniversityCompleted
-
Wilfrid Laurier UniversityCompleted
-
Wilfrid Laurier UniversityCompletedAnxiety | ShynessCanada
-
Massachusetts General HospitalActive, not recruitingFear | Anxiety Disorder of Childhood | ShynessUnited States
-
Inonu UniversityCompletedBeing Literate | Not Having Any Cognitive, Visual or Orthopedic Disabilities | Being Between the Ages of 50-65 | Having a Smart Phone | The Effect of Education on Cancer Screening on the Knowledge Level of Women | The Effect of Education on Cancer Screening on Women&Amp;#39;s Attitudes | The Effect...Turkey (Türkiye)
Clinical Trials on Leer te Durven!
-
Tartu University HospitalUniversity of TartuCompleted
-
International Hellenic UniversityCompleted
-
Immunwork, Inc.CompletedOverweight and ObesityAustralia
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI); University of Pennsylvania; University of Alabama... and other collaboratorsCompleted
-
Leiden UniversityNetherlands Organisation for Scientific Research; GGZ Delfland; Leids Universitair...RecruitingSocial Anxiety Disorder of ChildhoodNetherlands
-
Muğla Sıtkı Koçman UniversityCompleted
-
Establishment LabsCompletedBreast CancerBelgium, Spain
-
Luleå Tekniska UniversitetRecruitingHealthy Older AdultsSweden
-
University of AarhusNot yet recruitingObstructive Sleep Apnea | Tonsillar Hypertrophy
-
Singapore Eye Research InstituteRecruitingFuchs' Endothelial Dystrophy | Bullous Keratopathy | Mild to Moderate Corneal Endothelial Decompensation | Post-surgical Corneal Decompensation (Irreversible)Singapore